Metraipolis › archive › dc_3fa6ac22364e

Integrative omics and experimental validation reveal METTL17 and SLC27A1 as biomarkers and potential therapeutic targets in chronic kidney disease — Europe PMC PMID:41766913

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41766913
DOI
10.3389/fimmu.2026.1724740
License (as archived)
solo-consultazione
Archived
2026-11-05T20:30:04.980Z
SHA-256 of the archived text
0c1645a0b6a4c2f9d4eb81a28822aeb0c77a4a3d86d9e132257370db518cc310
Stable URL of this page
https://metraipolis.com/documento/dc_3fa6ac22364e

How to cite

Integrative omics and experimental validation reveal METTL17 and SLC27A1 as biomarkers and potential therapeutic targets in chronic kidney disease — Europe PMC PMID:41766913 — Europe PMC (en), https://europepmc.org/article/MED/41766913 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3fa6ac22364e (Metraipolis archive dc_3fa6ac22364e, sha256 0c1645a0b6a4c2f9d4eb81a28822aeb0c77a4a3d86d9e132257370db518cc310)
BibTeX
@misc{dc3fa6ac22364e,
  title = {Integrative omics and experimental validation reveal METTL17 and SLC27A1 as biomarkers and potential therapeutic targets in chronic kidney disease — Europe PMC PMID:41766913},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41766913},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3fa6ac22364e; sha256 0c1645a0b6a4c2f9d4eb81a28822aeb0c77a4a3d86d9e132257370db518cc310},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41766913. Agents can read the archived copy with the MCP tool read_document.